Key Takeaways
- • Ares Management (ARES) has a consensus analyst price target of $147.71–$173.27 USD over the next 12 months, representing upside of approximately 31–54% from recent trading levels near $112.61, with a high estimate of $222.00 and low of $104.00 across surveyed analysts.
- • The stock carries a GF Score of 80/100, a PE ratio of 59.44, and a PB ratio of 7.92, reflecting a premium valuation relative to historical averages; current market capitalization stands at $11.95 billion with an enterprise value of $105.29 billion.
- • Analyst consensus rating is "Buy" across 14–18 coverage sources, though one analyst lowered their target to $111.00 and maintained a neutral rating, indicating divergence within the research community on near-term momentum.
- • Price momentum metrics suggest ARES is currently trading near support levels, with the stock having gained $5.93 recently but facing valuation-based headwinds that warrant selective accumulation rather than aggressive positioning.
Summary
Ares Management Corporation (ARES) commands broad analyst coverage with 14–18 institutional researchers providing 12-month price targets that cluster around a consensus midpoint of $147.71–$173.27 USD. This represents meaningful upside from the stock's current trading price of $112.61, though the range of forecasts—spanning from a low of $104 to a high of $222—reflects material divergence in analyst conviction regarding the firm's near-term trajectory and long-term earnings power.
The valuation backdrop presents a mixed picture for institutional investors. Ares trades at a compressed PE multiple of 59.44x with a price-to-book ratio of 7.92x, positioning the stock in the upper quintile of asset management peers. The company's market capitalization of $11.95 billion contrasts sharply with its $105.29 billion enterprise value, a gap often indicative of significant leverage or obligations on the balance sheet. The GF Score of 80/100 signals above-average fundamental quality, though this elevated multiple suggests much of the investment case is priced into current levels.
Consensus sentiment remains solidly constructive, with the majority of research houses rating Ares a "Buy." However, divergence has emerged: while most analysts maintain bullish positioning with targets above $140, at least one research house lowered its target to $111.00 and held a neutral rating, signaling caution on near-term momentum and questioning whether the 31–54% upside embedded in consensus forecasts can be realized without earnings acceleration.
Price action has been modest; the stock recently gained $5.93 but remains near technical support levels, suggesting that investors are taking a measured approach to accumulation. For hedge funds and institutional allocators, Ares warrants selective positioning rather than conviction buying. The Buy consensus provides a favorable risk-reward framework, but the premium valuation and concentrated upside forecasts imply limited margin of safety until the firm demonstrates concrete earnings growth sufficient to justify its current multiple expansion.
The valuation backdrop presents a mixed picture for institutional investors. Ares trades at a compressed PE multiple of 59.44x with a price-to-book ratio of 7.92x, positioning the stock in the upper quintile of asset management peers. The company's market capitalization of $11.95 billion contrasts sharply with its $105.29 billion enterprise value, a gap often indicative of significant leverage or obligations on the balance sheet. The GF Score of 80/100 signals above-average fundamental quality, though this elevated multiple suggests much of the investment case is priced into current levels.
Consensus sentiment remains solidly constructive, with the majority of research houses rating Ares a "Buy." However, divergence has emerged: while most analysts maintain bullish positioning with targets above $140, at least one research house lowered its target to $111.00 and held a neutral rating, signaling caution on near-term momentum and questioning whether the 31–54% upside embedded in consensus forecasts can be realized without earnings acceleration.
Price action has been modest; the stock recently gained $5.93 but remains near technical support levels, suggesting that investors are taking a measured approach to accumulation. For hedge funds and institutional allocators, Ares warrants selective positioning rather than conviction buying. The Buy consensus provides a favorable risk-reward framework, but the premium valuation and concentrated upside forecasts imply limited margin of safety until the firm demonstrates concrete earnings growth sufficient to justify its current multiple expansion.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.